INS and metabolic dysfunction-associated steatotic liver disease: Interestingly, the lower HOMA-IR (Figure 5D) but higher insulin secretion index (Figure 5E) in the LMF-HSFx group compared to the placebo group, suggesting LMF-HSFx has the potential to attenuate the insulin resistance and to enhance the beta cell repair in NAFLD.